USA is India’s largest pharmaceutical importer and imported pharma products worth USD 6.5 billion from India in 2018. However, India had a miniscule share of 5.6% in USA’s total imports of pharmaceutical products worth USD 116 billion from the world in 2018.
With its robust pharmaceutical manufacturing capabilities, India has the potential to enhance its pharma exports to USA. MVIRDC World Trade Center Mumbai has, therefore, identified 10 products which constituted about 25% of USA’s pharma imports from the world in 2018 at USD 29.6 billion and about 17% of USA’s pharma imports from India in 2018, amounting to USD 1 billion.
USA’s imports of these products from India individually constituted a share of less than 10% and more than 2% in USA's imports of these products from the world in 2018. However, USA’s imports of these products from India cumulatively constituted only 3.7% of its imports of these products from the world in 2018.
Indian pharma exporters can increase their presence in the US market through exporting these products: